Aliben News | The 2023 National High end Mass Spectrometer R&D and Application Achievement Appraisal Conference and Series A Financing Signing Ceremony have been successfully concluded

Aliben Company and Sichuan Development Pengzhou Global Biomedical Fund

On site signing ceremony for Series A financing

Afternoon of May 25th, 2023, The "2023 Domestic High end Mass Spectrometer R&D and Application Achievement Appraisal Conference and Series A Financing Signing Ceremony" jointly organized by the Chinese Instrumentation Society, Sichuan University, and Chengdu Aliben Technology Co., Ltd. (hereinafter referred to as Aliben Technology) was held at the Shangri La Hotel in Wuhou District, Chengdu. The conference invited leaders of the Pengzhou Municipal Party Committee, academicians, experts, and partners to attend and witness the event.

The conference was divided into two stages. The first stage was the signing ceremony of the A-round financing between Aliben Technology and Chuanfa Pengzhou Global Biomedical Fund. The ceremony was attended by Jiang Ming, Mayor of Pengzhou City, Liu Jun, General Manager of Chuanfa Medical Industry Group, Li Weimin, Dean of West China Hospital of Sichuan University, and Duan Yixiang, Chairman of Aliben Technology.

Aliben Technology Chairman Duan Yixiang warmly welcomes and thanks the guests

Mayor Jiang Ming of Pengzhou stated that as one of the four new medium-sized industrial cities planned and developed by Chengdu, Pengzhou has been actively promoting technological innovation and school enterprise cooperation for a long time. Pengzhou is known as the "thousand year medicine town, hundred year medicine city" and has attracted over 200 major health enterprises to settle in so far. He is very grateful for the support provided by Sichuan Development Pengzhou Global Biopharmaceutical for Pengzhou's development and hopes that Alibaba can achieve better results through this financing.

Mayor Jiang Ming of Pengzhou City delivered a speech

Liu Jun, General Manager of Chuanfa   Medical Industry Group, expressed his support and recognition for Aliben Technology in his signing speech. Aliben's human exhaled breath detection mass spectrometer provides a new solution for cancer screening with high accuracy, high accessibility, and ultra-low cost. As a technology innovation enterprise serving the fields of medicine and health, environmental testing, high-end scientific research, etc., its professionalism and innovation are highly recognized by the industry. This in-depth and friendly cooperation will also have a profound impact on the medical equipment industry.

Liu Jun, General Manager of Chuanfa Medical Industry Group, delivered a speech

Li Weimin, Dean of West China Hospital of Sichuan University, warmly congratulated on the financing signing. He stated that high-end medical care and equipment are the most concerned and anticipated by the pharmaceutical industry, and West China Hospital is also doing its best to provide sufficient medical security and resources for society. As a partner of West China Hospital, Aliben Technology's human exhaled breath detection mass spectrometer has been widely recognized and accepted. The independent innovation and research and development capabilities of Aliben are evident in the industry, and this signing is also a fusion of the advantages of both parties. We hope that Aliben Technology will live up to expectations and achieve higher breakthroughs.

Li Weimin, Dean of West China Hospital of Sichuan University, delivered a speech

Subsequently, Hao Min, Deputy General Manager of Chuanfa Medical Industry Group, and Yang Yanting, General Manager of Aliben Technology, signed a contract with each other. The guests present witnessed this exciting moment together.

Chuan Development Medical Industry Group and Aliben Technology signed a two party contract

Zuo Yi, Chairman of Aliben Technology, Duan Yixiang

Hao Min, Deputy General Manager of Zuo Erchuan Development Medical Industry Group

Yang Yanting, General Manager of Zuo San Aliben Technology

Liu Jun, General Manager of Left Sichuan Development Medical Industry Group

After a ten minute tea break, the second stage of this conference - the identification meeting for the research and application results of domestic high-end mass spectrometers - will follow.

Two academicians, Academician You Zheng and Academician Tan Jiubin, were invited to attend this appraisal meeting. Fu Qiang, Deputy Chief Engineer of China Environmental Monitoring Station, Sun Yang, Researcher of the Institute of Atmospheric Physics of the Chinese Academy of Sciences, Ding Chuanfan, Dean of the School of Materials Science and Chemical Engineering of Ningbo University, Yu Tingquan, Director of the Seventh Research Institute of China Aerospace Science and Technology Corporation, Fan Ting, Researcher of the Chengdu Institute of Organic Chemistry of the Chinese Academy of Sciences, and Huang Yan, Deputy Director of the Health Management Center of West China Hospital of Sichuan University, participated in the identification work as an expert group.

On site appraisal meeting for the research and application achievements of domestic high-end mass spectrometers

Zhang Tong, Secretary General of the Chinese Instrument and Meter Society, introduced the background of the conference,

identification materials, and members of the identification committee

Liu Chao, Dean of the Research Institute of Sichuan University, delivered a welcome speech

The meeting officially began, with Duan Yixiang, Chairman of Aliben Technology, giving a defense and explanation on the background, application promotion, and economic and social benefits of the project. He also introduced four independently developed and produced instruments and equipment, including PTR-TOF MS 6000 proton transfer reaction time-of-flight mass spectrometer, handheld lithium material rapid detector, offline exhaled gas collector, and online gas analysis mass spectrometer, to the experts.

Experts evaluated and inquired about the details and application of the product, and the project team answered questions one by one.

Aliben Technology Chairman Duan Yixiang introduces the product

Product Display

(Swipe right to see more)

Expert questions, project team defense

After carefully listening to the basic situation of the instruments and equipment, as well as the overall progress of the work, the experts of the appraisal committee strictly reviewed the technical materials such as the development work report, technical report, scientific and technological novelty search report, and application situation. After the appraisal and review by the experts of the appraisal committee, the achievement appraisal was successfully passed.

The successful holding of the National High end Mass Spectrometer R&D and Application Achievement Appraisal Conference and Series A Financing Signing Ceremony marks a new stage of development for Aliben Technology. Aliben will adhere to the corporate spirit of "pursuing excellence, uniqueness, focusing on precision, and insisting on innovation", continue to move forward, constantly break through itself, and live up to expectations and create new achievements!

Pengzhou releases #Technological innovation drives high-quality development! The 2023 National High end Mass Spectrometer R&D and Application Achievement Appraisal Conference and Series A Financing Signing Ceremony were held#‍